RVTYRevvity

Health care · Lab Instruments · NYSE

We are a leading provider of health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. 10-K, Item 1

Employees: 11,000
Headquarters: Waltham, MA
CEO: Prahlad R. Singh
Next results: around Jan 12, 2027

Compare with peers → Embed

The biggest changes in the 10-K filed 2026-02-24, this fiscal year against the last, and the sentences in the MD&A (Item 7) where management explains them, quoted word for word. Tickdelta picks sentences that name the line, a direction and a cause. It does not write explanations of its own.

Net income

-10.8% Big change FY to 2025-12-28 vs 2024-12-29

The MD&A has no sentence that names a cause for this change. That can be worth a question: ask about the filing.

Cash from operations

-7.2% FY to 2025-12-28 vs 2024-12-29

“The cash provided by operating activities for fiscal year 2025 was principally a result of income from continuing operations of $239.9 million, adjustments for non-cash charges aggregating to $445.9 million, including depreciation and amortization of $405.3 million, and a net cash decrease from changes in working capital of $96.8 million, primarily due to timing of collections in China during fiscal year 2025.”
Read it in the 10-K ↗

Revenue

+3.7% FY to 2025-12-28 vs 2024-12-29

“Our overall revenue in fiscal year 2025 increased by $101.1 million, or 4%, as compared to fiscal year 2024, reflecting an increase of $68.5 million, or 5%, in Diagnostics segment revenue and an increase of $32.5 million, or 2%, in Life Sciences segment revenue.”
Read it in the 10-K ↗

“Revenue for fiscal year 2025 was $2,856.1 million, as compared to $2,755.0 million for fiscal year 2024, an increase of $101.1 million, or 4%, which includes an approximate 1% increase in revenue attributable to favorable changes in foreign exchange rates.”
Read it in the 10-K ↗

Operating margin

12.6% → 12.5% (-0.1 pts) FY to 2025-12-28 vs 2024-12-29

“Our consolidated operating margin decreased 10 basis points in fiscal year 2025, as compared to fiscal year 2024, due to gross margin headwinds, as discussed above, partially offset by productivity and cost containment initiatives.”
Read it in the 10-K ↗

“Segment operating margin decreased 139 basis points to 32.0% in fiscal year 2025, as compared to 33.4% in fiscal year 2024, primarily due to unfavorable changes in volume leverage and foreign exchange rates, product mix shifts and investments in new product development and digital capabilities.”
Read it in the 10-K ↗

Changes are computed from the XBRL figures in the same 10-K. Hover a number to see the line item. Open the 10-K ↗

Work on RVTY in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/RVTY/export.csv") into a cell.